Clinical Trials Directory

Trials / Completed

CompletedNCT03102411

Impact of Diet on Functional Gastrointestinal Symptoms

Impact of Diet on Functional Gastrointestinal Symptoms; a National Population Based Survey

Status
Completed
Phase
Study type
Observational
Enrollment
1,881 (actual)
Sponsor
TriHealth Inc. · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

This cross-sectional survey study is to determine the prevalence of functional gastrointestinal (GI) disorders in the general population and to describe common triggers for food-related GI symptoms.

Detailed description

Functional gastrointestinal disorders, involving symptoms such as gas/bloating, diarrhea, constipation and abdominal pain, are estimated to impact between 35 and 45 million Americans, an overwhelming 15-20% of the population. These symptoms are responsible for upwards of 20 billion dollars in healthcare costs and extensive loss of quality of life for sufferers. Moreover, many patients suffer in silence, with 67% of subjects waiting more than a year before treatment, and 11% waiting over 10 years. Irritable bowel syndrome is the most prevalent functional gastrointestinal disorder, and several recent studies support the idea that dietary modifications may be key to alleviating this condition. The purpose of this study is to document gastrointestinal symptoms among the US population, as well as to ascertain awareness and utilization of dietary treatments that exist.

Conditions

Timeline

Start date
2017-03-09
Primary completion
2017-09-15
Completion
2017-09-15
First posted
2017-04-05
Last updated
2019-01-25
Results posted
2019-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03102411. Inclusion in this directory is not an endorsement.